Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
All content for On The Pen With Dave Knapp is the property of Bleav, Dave Knapp Founder of On The Pen and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
GLP-1 Weight Loss, Why It's About So Much More for Patients
On The Pen With Dave Knapp
50 minutes 3 seconds
1 month ago
GLP-1 Weight Loss, Why It's About So Much More for Patients
Last week, Dr. Robin Pashby’s viral presentation “What We Carry” lit up the obesity and GLP-1 community. If you missed it, go watch that talk first — it’s one of the most powerful pieces on living with obesity you’ll ever see.
This is my in-depth interview with Dr. Pashby, where we dig deeper into the stories behind “What We Carry.” She opens up about the scale’s power, the rules we live by, the “fire escape” moments we all carry, and what it truly means to separate weight from worth.
If her viral talk hit you in the heart, this conversation will help you process it, personalize it, and maybe even begin to let go of some of that hidden weight.
On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
